FDA Draft Guidance Details Regulatory Considerations for Medical Device Software
- November 05, 2021
The Food and Drug Administration (FDA) released November 3 draft guidance that describes the recommended documentation to include in premarket submissions for the agency to evaluate the safety and effectiveness of medical device software.
ARTICLE TAGS
You must be logged in to access this content.